Glen Eagle Advisors, LLC Bio Xcel Therapeutics, Inc. Transaction History

Glen Eagle Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Aug 13, 2024	SELL	$20.12 - $35.09 $6,639 - $11,579	-330 Closed	0 $0
Q3 2021 Aug 13, 2024	SELL	$23.84 - $32.03 $1,788 - $2,402	-75 Reduced 18.52%	330 $10 Million
Q2 2021 Aug 13, 2024	BUY	$29.06 - $38.83 $3,923 - $5,242	135 Added 50.0%	405 $11.8 Million
Q1 2021 Aug 13, 2024	BUY	$39.04 - $64.6 $1,171 - $1,937	30 Added 12.5%	270 $11.7 Million
Q4 2020 Aug 13, 2024	BUY	$42.46 - $56.58 $10,190 - $13,579	240 New	240 $11.1 Million
Q2 2020 Aug 13, 2024	BUY	$17.62 - $58.71 $440 - $1,467	25 New	25 $1.33 Million

8.54M

34.5K

59.4K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $51.8M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Glen Eagle Advisors, LLC with notifications on news.